UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041863
Receipt number R000047791
Scientific Title Effects of consumption of the test food on the oral cavity environment in healthy subjects: an open-label trial
Date of disclosure of the study information 2020/09/23
Last modified on 2021/04/01 09:26:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of consumption of the test food on the oral cavity environment in healthy subjects

Acronym

Effects of consumption of the test food on the oral cavity environment in healthy subjects

Scientific Title

Effects of consumption of the test food on the oral cavity environment in healthy subjects: an open-label trial

Scientific Title:Acronym

Effects of consumption of the test food on the oral cavity environment in healthy subjects

Region

Japan


Condition

Condition

Healthy Japanese subjects

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the effects of consumption of the test food on the oral cavity environment in healthy subjects

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

The measured values and logarithmic values of Porphyromonas gingivalis (P. gingivalis)

Key secondary outcomes

1. The questionnaires (Likert Scale method)

2. Gingival Index (GI), Plaque Index (PlI), bleeding on probing, depth of periodontal pockets, and progression of dental caries


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Take the test food one tablet a day before bedtime for six weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Healthy Japanese adult subjects

2. Subjects who are judged to be eligible to participate in the study by the physician

3. Subjects who has a high measured value of P. gingivalis at screening (before consumption)

4. Subjects who has a high measured value of GI at screening (before consumption)

Key exclusion criteria

Subjects who
1.undergoing medical treatment or having a medical history of malignant tumor, heart failure, or myocardial infarction

2. have a pacemaker or an implantable cardioverter defibrillator (ICD)

3. undergoing treatment for any of the following chronic disease: cardiac arrhythmia, liver disorder, kidney disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or any other chronic diseases

4. use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily

5. currently taking medicines (include herbal medicines) and supplements

6. have used antibacterial drugs within the last three months before the agreement to participate in this trial

7. allergic to medications and/or the test-food-related products

8. regularly use gargle medicine

9. use artificial tooth, post crowns, dentures, or implants

10. regularly use floss, interdental cleaner, and mouthwash

11. have receiving dental maintenance care at dental clinic, such as removing dental plaques and dental tartars within the last three months

12. have a medical history, current illness, or are suspected to be a Sjogren's syndrome

13. have disorders associated with salivary gland such as dry mouse and salivary stone disease

14. undergoing medical treatment of periodontal disease or dental caries

15. are under treatment or diagnosed with any of dental diseases

16. are smokers, or started smoking cessation within a year before the invitation to participate in this trial

17. are lactating, pregnant, or intending to become pregnant

18. have been enrolled in other clinical trials within the last three months before the invitation to participate in this trial, or plan to participate in another trial during this trial

19. are judged by the principal investigator as ineligible to participate in the trial

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Masahiko
Middle name
Last name Horiuchi

Organization

Medical Corporation Yuseikai, Horiuchi Dental Clinic

Division name

Director

Zip code

141-0022

Address

2F AM Bldg., 2-3-3, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.

TEL

03-3449-1033

Email

dr_horiuchi@orthomedico.jp


Public contact

Name of contact person

1st name Naoko
Middle name
Last name Suzuki

Organization

ORTHOMEDICO Inc.

Division name

R&D Department

Zip code

112-0002

Address

2F Sumitomo Fudosan Korakuen Bldg., 1-4-1, Koishikawa, Bunkyo-ku, Tokyo, Japan.

TEL

03-3818-0610

Homepage URL


Email

nao@orthomedico.jp


Sponsor or person

Institute

ORTHOMEDICO Inc.

Institute

Department

Personal name



Funding Source

Organization

DENSO CORPORATION

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Medical Corporation Yuseikai, Horiuchi Dental Clinic

Medical Corporation Seishinkai, Takara Clinic

Nerima Medical Association, Minami-machi Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

the ethical committee of the Takara Clinic, Medical Corporation Seishinkai

Address

9F Taisei Building, 2-3-2, Higashi-gotanda, Shinagawa-ku, Tokyo, Japan.

Tel

03-5793-3623

Email

IRB@takara-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

医療法人社団優正会 堀内歯科医院 (東京都)
Medical Corporation Yuseikai, Horiuchi Dental Clinic (Tokyo, Japan)

医療法人社団盛心会 タカラクリニック (東京都)
Medical Corporation Seishinkai, Takara Clinic (Tokyo, Japan)

南町医院 (東京都)
Nerima Medical Association, Minami-machi Clinic (Tokyo, Japan)


Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

14

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 09 Month 15 Day

Date of IRB

2020 Year 09 Month 15 Day

Anticipated trial start date

2020 Year 09 Month 23 Day

Last follow-up date

2020 Year 12 Month 18 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 09 Month 23 Day

Last modified on

2021 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047791


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name